*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C413 - Malignant neoplasm of ribs, sternum and clavicle - as a primary diagnosis code | C413 - Malignant neoplasm of ribs, sternum and clavicle - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 6.41 | |
| Readmission Rate (%) | 24.61 | |
| Unplanned Readmission Rate (%) | 8.61 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 517: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 478: BIOPSIES OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 516: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 496: LOCAL EXCISION AND REMOVAL OF INTERNAL FIXATION DEVICES EXCEPT HIP AND FEMUR WITH COMPLICATION OR COMORBIDITY (CC) | DRG 501: SOFT TISSUE PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 43,598 | ||||
| Total Hospitalizations with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | 20 | ||||
| DRG Share of Total Hospitalizations | 0.13 | ||||
| % of Total ICD C413 - Malignant neoplasm of ribs, sternum and clavicle in DRG | 12.99 | ||||
| Avg LOS at DRG | 2.56 | ||||
| Avg LOS with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | 4.05 | ||||
| Readmission Rate at DRG | 13.58 | ||||
| Readmission Rate with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | NA | ||||
| Unplanned Readmission Rate at DRG | 5.0 | ||||
| Unplanned Readmission Rate with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | NA | ||||
| Total Medicare payments at DRG | $405,277,239 | ||||
| Total Medicare payments with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | $226,154 | ||||
| Total Medicare payment per Day at DRG | $3,633 | ||||
| Total Medicare payment per Day with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | $2,792 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,296 | ||||
| Total Medicare payment per Hospitalization with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | $11,308 | ||||
| Total Medicare Charges at DRG | $2,108,105,162 | ||||
| Total Medicare Charges with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | $1,601,401 | ||||
| Avg Charges at DRG | $48,353 | ||||
| Avg Charges with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | $80,070 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | NA | ||||
| SNF Discharge Rate at DRG | 16.27 | ||||
| SNF Discharge Rate with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | NA | ||||
| Home Discharge Rate at DRG | 57.43 | ||||
| Home Discharge Rate with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 478: BIOPSIES OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 516: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 517: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | 23 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD C413 - Malignant neoplasm of ribs, sternum and clavicle in DRG | 4.73 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | 5.91 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | NA | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | NA | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | $284,259 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | $2,090 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | $12,359 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | $1,615,226 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | $70,227 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | NA | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | NA | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 496: LOCAL EXCISION AND REMOVAL OF INTERNAL FIXATION DEVICES EXCEPT HIP AND FEMUR WITH COMPLICATION OR COMORBIDITY (CC) | DRG 543: PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 501: SOFT TISSUE PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 181: RESPIRATORY NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 542: PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 5,667 | ||||
| Total Hospitalizations with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | 16 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD C413 - Malignant neoplasm of ribs, sternum and clavicle in DRG | 3.29 | ||||
| Avg LOS at DRG | 4.53 | ||||
| Avg LOS with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | 7.81 | ||||
| Readmission Rate at DRG | 16.34 | ||||
| Readmission Rate with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | NA | ||||
| Unplanned Readmission Rate at DRG | 7.49 | ||||
| Unplanned Readmission Rate with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | NA | ||||
| Total Medicare payments at DRG | $68,611,253 | ||||
| Total Medicare payments with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | $259,001 | ||||
| Total Medicare payment per Day at DRG | $2,670 | ||||
| Total Medicare payment per Day with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | $2,072 | ||||
| Total Medicare payment per Hospitalization at DRG | $12,107 | ||||
| Total Medicare payment per Hospitalization with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | $16,188 | ||||
| Total Medicare Charges at DRG | $385,973,252 | ||||
| Total Medicare Charges with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | $2,390,743 | ||||
| Avg Charges at DRG | $68,109 | ||||
| Avg Charges with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | $149,421 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | NA | ||||
| SNF Discharge Rate at DRG | 24.74 | ||||
| SNF Discharge Rate with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | NA | ||||
| Home Discharge Rate at DRG | 37.06 | ||||
| Home Discharge Rate with ICD C413 - Malignant neoplasm of ribs, sternum and clavicle | NA |